186 related articles for article (PubMed ID: 16764675)
1. Attempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral load.
Shata MT; Pfahler W; Brotman B; Lee DH; Tricoche N; Murthy K; Prince AM
J Med Primatol; 2006 Jun; 35(3):165-71. PubMed ID: 16764675
[TBL] [Abstract][Full Text] [Related]
2. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
[TBL] [Abstract][Full Text] [Related]
3. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.
Sällberg M; Hughes J; Javadian A; Ronlov G; Hultgren C; Townsend K; Anderson CG; O'Dea J; Alfonso J; Eason R; Murthy KK; Jolly DJ; Chang SM; Mento SJ; Milich D; Lee WT
Hum Gene Ther; 1998 Aug; 9(12):1719-29. PubMed ID: 9721082
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
[TBL] [Abstract][Full Text] [Related]
7. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Oka Y; Akbar SM; Horiike N; Joko K; Onji M
Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.
Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
J Med Virol; 2002 Apr; 66(4):452-60. PubMed ID: 11857521
[TBL] [Abstract][Full Text] [Related]
11. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
[TBL] [Abstract][Full Text] [Related]
12. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.
Godon O; Fontaine H; Kahi S; Meritet JF; Scott-Algara D; Pol S; Michel ML; Bourgine M;
Mol Ther; 2014 Mar; 22(3):675-684. PubMed ID: 24394187
[TBL] [Abstract][Full Text] [Related]
13. Phase IIb trial of
Yang FQ; Rao GR; Wang GQ; Li YQ; Xie Y; Zhang ZQ; Deng CL; Mao Q; Li J; Zhao W; Wang MR; Han T; Chen SJ; Pan C; Tan DM; Shang J; Zhang MX; Zhang YX; Yang JM; Chen GM
World J Gastroenterol; 2017 Jan; 23(2):306-317. PubMed ID: 28127204
[TBL] [Abstract][Full Text] [Related]
14. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee.
Pancholi P; Lee DH; Liu Q; Tackney C; Taylor P; Perkus M; Andrus L; Brotman B; Prince AM
Hepatology; 2001 Feb; 33(2):448-54. PubMed ID: 11172348
[TBL] [Abstract][Full Text] [Related]
15. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice].
Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection.
Enomoto M; Nishiguchi S; Tamori A; Kozuka R; Hayashi T; Kohmoto MT; Jomura H; Morikawa H; Murakami Y; Shiomi S; Kawada N
J Interferon Cytokine Res; 2015 Aug; 35(8):613-20. PubMed ID: 25884105
[TBL] [Abstract][Full Text] [Related]
17. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B.
Wen YM; Qu D; Zhou SH
Int Rev Immunol; 1999; 18(3):251-8. PubMed ID: 10614727
[TBL] [Abstract][Full Text] [Related]
18. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
20. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
